Lyxumia subcutaneous injection 300μg (YJ code: 2499415G1024, standard: 300μg x 3mL x 1 kit), manufactured by Sanofi, contains lixisenatide. This once-daily injectable GLP-1 receptor agonist is used in adults with type 2 diabetes to help control blood glucose levels, often in combination with other diabetes medications.
Lyxumia subcutaneous injection 300μg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).